Paraplegia News and Research RSS Feed - Paraplegia News and Research

Paraplegia is an impairment in motor or sensory function of the lower extremities. It is usually the result of spinal cord injury or a congenital condition such as spina bifida which affects the neural elements of the spinal canal.
TSRI study points way to potential therapies for hereditary spastic paraplegia

TSRI study points way to potential therapies for hereditary spastic paraplegia

Scientists at The Scripps Research Institute have discovered that a gene mutation linked to hereditary spastic paraplegia, a disabling neurological disorder, interferes with the normal breakdown of triglyceride fat molecules in the brain. The TSRI researchers found large droplets of triglycerides within the neurons of mice modeling the disease. [More]
Researchers develop artificial connection from brain to legs by bypassing with computer interface

Researchers develop artificial connection from brain to legs by bypassing with computer interface

Gait disturbance in individuals with spinal cord injury is attributed to the interruption of neural pathways from brain to the spinal locomotor center, whereas neural circuits locate below and above the lesion maintain most of their functions. [More]
FDA clears ReWalk wearable robotic exoskeleton for home usage

FDA clears ReWalk wearable robotic exoskeleton for home usage

Exoskeleton leader ReWalk Robotics announced today that the U.S. Food and Drug Administration has cleared the company's ReWalk Personal System for use at home and in the community. ReWalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with Spinal Cord Injury (SCI) to stand upright and walk. [More]
FDA approves marketing of first motorized device for patients with spinal cord injuries

FDA approves marketing of first motorized device for patients with spinal cord injuries

The U.S. Food and Drug Administration today allowed marketing of the first motorized device intended to act as an exoskeleton for people with lower body paralysis (paraplegia) due to a spinal cord injury. [More]
HAL robot suit helps paraplegics

HAL robot suit helps paraplegics

For most paraplegic patients, being able to walk again remains a dream. The HAL robot suit can help them regain a certain degree of mobility and activity. An expert team at the Centre for Neurorobotic Movement Training (ZNB) in Bochum has been testing the exoskeleton that was originally developed in Japan since 2011. With excellent results. [More]

New potential treatment for paraplegic patients

People with severe injuries to their spinal cord currently have no prospect of recovery and remain confined to their wheelchairs. Now, all that could change with a new treatment that stimulates the spinal cord using electric impulses. [More]
Study shows spinal stimulation therapy may have potential to change prognosis of people with paralysis

Study shows spinal stimulation therapy may have potential to change prognosis of people with paralysis

Four people with paraplegia are able to voluntarily move previously paralyzed muscles as a result of a novel therapy that involves electrical stimulation of the spinal cord, according to a study funded in part by the National Institutes of Health and the Christopher & Dana Reeve Foundation. [More]
UC San Diego researchers uncover causes for hereditary spastic paraplegia

UC San Diego researchers uncover causes for hereditary spastic paraplegia

In a study published in the January 31, 2014 issue of Science, an international team led by scientists at the University of California, San Diego School of Medicine report doubling the number of known causes for the neurodegenerative disorder known as hereditary spastic paraplegia. HSP is characterized by progressive stiffness and contraction of the lower limbs and is associated with epilepsy, cognitive impairment, blindness and other neurological features. [More]

ARGO Medical partners with YASKAWA for global expansion of ReWalk exoskeleton device

ARGO Medical Technologies has partnered with innovative robotics experts YASKAWA Electric Corporation as it continues the global expansion of its ReWalk exoskeleton device which enables individuals with lower limb disabilities such as paraplegia to walk. [More]
Journal of Spinal Cord Medicine's July issue focuses on assistive technology for spinal cord injury

Journal of Spinal Cord Medicine's July issue focuses on assistive technology for spinal cord injury

The July issue of the Journal of Spinal Cord Medicine focuses on, "Advances in Technology for People with Spinal Cord Injury." Guest Editor Rory Cooper, PhD, is a member of the journal's Editorial Board. Dr. Cooper is the FISA/PVA Endowed Chair and a Distinguished Professor of the Department of Rehabilitation Science and Technology, School of Health and Rehabilitation Sciences, University of Pittsburgh. [More]

ARGO launches ReWalk Rehabilitation 2.0 system

ARGO Medical Technologies has unveiled the newest generation of its ReWalk Rehabilitation exoskeleton that enables individuals with spinal cord injuries the ability to walk again. [More]
Bionic devices: an interview with Dr Rylie Green

Bionic devices: an interview with Dr Rylie Green

Bionic devices are implants which replace biological functions which have been lost due to nerve damage. They use electrical signals to stimulate the remaining nerve cells following disease or injury. Although the term bionic was only coined in the late 1950s, the earliest bionic devices were cardiac pacemakers, developed in the early 1900s. However the first commercial implantable units were not available until the 1950s. [More]
University of Tübingen heads Neuromics consortium

University of Tübingen heads Neuromics consortium

Work has begun on Neuromics, a major project headed by Tübingen's Professor Olaf Riess; the project beat out ten other first-class applications to attain €12m euros in EU funding over five years. [More]
Powered exoskeleton provides more independence to people with severe spinal cord injuries

Powered exoskeleton provides more independence to people with severe spinal cord injuries

The dream of regaining the ability to stand up and walk has come closer to reality for people paralyzed below the waist who thought they would never take another step. [More]
Neuralstem prices registered direct offering of 7,000,000 shares of common stock

Neuralstem prices registered direct offering of 7,000,000 shares of common stock

Neuralstem, Inc. today announced the pricing of a registered direct offering of 7,000,000 shares of its common stock, offered at a price to the public of $1.00 per share. [More]
Q Therapeutics licenses Neuralstem's Spinal Cord Delivery Platform and Floating Cannula

Q Therapeutics licenses Neuralstem's Spinal Cord Delivery Platform and Floating Cannula

Neuralstem, Inc. announced that it has granted the first licenses for use of its Spinal Cord Delivery Platform and Floating Cannula, for delivering therapeutic agents to the spinal cord, to Salt Lake City-based Q Therapeutics. [More]
Preliminary research findings from Kessler Foundation’s Ekso device study on SCI

Preliminary research findings from Kessler Foundation’s Ekso device study on SCI

Kessler Foundation has released preliminary research findings from its clinical study of the wearable robotic exoskeletal device, Ekso. Gail Forrest, PhD, assistant director of Human Performance and Engineering Research, presented the Ekso research data on September 3, at the meeting of the Academy of Spinal Cord Injury Professionals at the Rio Suites in Las Vegas. Dr. Forrest directs mobility research at the Foundation, including activity-based locomotor therapy, functional electrical stimulation, and treadmill training with the LokomatPro v6, as well as Ekso. [More]
ARGO Medical, Cyclone Technologies announce availability of ReWalk exoskeleton system

ARGO Medical, Cyclone Technologies announce availability of ReWalk exoskeleton system

Exoskeleton technology leader, ARGO Medical Technologies, along with mobility solutions provider, Cyclone Technologies, announced today that Claire Lomas has become the first person to take home an exoskeleton system for personal use. [More]
Exoskeleton technology now available to take home

Exoskeleton technology now available to take home

Exoskeleton technology leader, ARGO Medical Technologies, along with mobility solutions provider, Cyclone Technologies, announced today that Claire Lomas has become the first person to take home an exoskeleton system for personal use. Claire demonstrated her personal ReWalk™ at the annual International Spinal Cord Society (ISCoS) meeting held at the Queen Elizabeth II Conference Center. [More]
Neuralstem completes NSI-566 Phase I trial on amyotrophic lateral sclerosis

Neuralstem completes NSI-566 Phase I trial on amyotrophic lateral sclerosis

Neuralstem, Inc. announced the completion of the Phase I trial of its NSI-566 spinal cord neural stem cells for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), with the eighteenth patient treated. [More]